|
AstraZeneca and Bristol-Myers Squibb resubmit dapagliflozin New Drug Application
|
25 July 2013 |
|
AstraZeneca collaborates with Cambridge medical research institutions to advance cancer research
|
09 July 2013 |
|
AstraZeneca selects location for new global R&D centre and corporate headquarters
|
19 June 2013 |
|
MedImmune, AstraZeneca's biologics arm, and NGM Biopharmaceuticals announce agreement to discover and develop therapies for diabetes and obesity
|
17 June 2013 |
|
AstraZeneca to acquire Pearl Therapeutics to strengthen respiratory portfolio
|
10 June 2013 |
|
AstraZeneca to acquire Omthera Pharmaceuticals including NDA-ready novel dyslipidemia treatment to complement cardiovascular portfolio
|
28 May 2013 |
|
AstraZeneca issues update on accelerated oncology pipeline
|
16 May 2013 |
|
AstraZeneca first quarter results 2013
|
25 April 2013 |
|
MedImmune, AstraZeneca's biologics unit, acquires AlphaCore Pharma
|
03 April 2013 |
|
AstraZeneca settles litigation over CRESTOR patent
|
25 March 2013 |